Login / Signup

Argininamide-type neuropeptide Y Y1 receptor antagonists: the nature of N ω-carbamoyl substituents determines Y1R binding mode and affinity.

Jonas BuschmannTheresa SeilerGuenther BernhardtMax KellerDavid Wifling
Published in: RSC medicinal chemistry (2020)
The recently resolved crystal structure of the neuropeptide Y Y1 receptor (Y1R), co-crystallized with the high-affinity (pK i: 10.11), argininamide-type Y1R antagonist UR-MK299 (2), revealed that the N ω-carbamoyl substituent (van der Waals volume: 139 Å3) is deeply buried in the receptor, occupying a hydrophobic pocket. We synthesized and characterized a series of argininamides, structurally related to 2. Y1R affinity decreased with increasing size of the carbamoyl residue (minimal pK i: 5.67). Exceeding a critical size of the substituent (van der Waals volume: 212 Å3), the ligands bound in an inverted mode with the carbamoyl side chain located at the surface of the receptor, as suggested by induced-fit docking and MD simulations.
Keyphrases
  • molecular dynamics
  • binding protein
  • high glucose
  • diabetic rats
  • ionic liquid
  • drug induced
  • mass spectrometry
  • endothelial cells